LifeStance Health (LFST) Receivables (2020 - 2026)

LifeStance Health has disclosed Receivables across 7 years of filings, most recently posting $122.9 million for Q1 2026.

• In Q1 2026, Receivables fell 12.43% year-over-year to $122.9 million; the TTM figure through Mar 2026 stood at $122.9 million (down 12.43% YoY), while the FY2025 annual figure was $99.5 million, down 24.64% from the prior year.
• Receivables grew to $122.9 million in Q1 2026, from $99.5 million in the prior quarter.
• Over the last five years, Receivables for LFST reached as high as $175.9 million in Q1 2024 and fell as low as $95.0 million in Q1 2022.
• The 5-year median for Receivables is $122.9 million (2026), against an average of $127.7 million.
• Annual changes were most pronounced in 2022 — Receivables jumped 54.47% — and 2025, when it decreased 24.64%.
• A 5-year view of Receivables shows it stood at $101.5 million in 2022, then increased by 23.77% to $125.6 million in 2023, then rose by 5.08% to $132.0 million in 2024, then declined by 24.64% to $99.5 million in 2025, then increased by 23.53% to $122.9 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $122.9 million, $99.5 million, and $121.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.